Experimental toxicology of ASTA Z 7557 (INN mafosfamide) View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1984-06

AUTHORS

Joerg Pohl, Peter Hilgard, Wolfgang Jahn, Hans-Juergen Zechel

ABSTRACT

The LD 50 of Z 7557 in mice was between 500 and 625 mg/kg after i.v. and around 2310 mg/kg after oral administration. The corresponding LD 10 was around 435 mg/kg (i.v.) or 1100-1250 mg/kg (p.o.), respectively. The LD 50 values in rats were in the range of 250-310 mg/kg after i.v. administration and around 1000-1250 mg/kg if given orally. With repeated daily i.v. injections only 70% of the daily dose contributed to lethality. A second administration of Z 7557 to rats after reversal of all toxic signs from the first administration induced the same symptoms and degree of toxicity as the initial injection. Reversible myelosuppression was the predominant feature of toxicity in mice and rats, but at equimolar doses this myelotoxicity was less than half that of cyclophosphamide (CP). First signs of immunosuppression were seen only at 100 mg/kg i.v.. No severe urotoxicity was observed in rats with single i.v. doses up to 192 mg/kg. This might be due to the fast and complete renal excretion of the thiol moiety of Z 7557, whereas the activated oxazaphosphorine component occurred in the urine only to a much smaller amount, as could be shown by a pilot pharmacokinetic study. In conclusion, Z 7557 appeared to have an overall tolerance in rats and mice similar to cyclophosphamide but was clearly less toxic with respect to the bone marrow, the immune system and the urinary tract. More... »

PAGES

201-206

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf00232352

DOI

http://dx.doi.org/10.1007/bf00232352

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1023463040

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/6469515


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibody Formation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bone Marrow", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclophosphamide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kinetics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lethal Dose 50", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Organ Size", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats, Inbred Strains", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Urinary Bladder", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Department of Experimental Cancer Research and Toxicological Institute, Asta-Werke AG, Degussa Pharma Gruppe, Bielefeld, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pohl", 
        "givenName": "Joerg", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Experimental Cancer Research and Toxicological Institute, Asta-Werke AG, Degussa Pharma Gruppe, Bielefeld, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hilgard", 
        "givenName": "Peter", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Experimental Cancer Research and Toxicological Institute, Asta-Werke AG, Degussa Pharma Gruppe, Bielefeld, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jahn", 
        "givenName": "Wolfgang", 
        "id": "sg:person.0672360256.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0672360256.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Experimental Cancer Research and Toxicological Institute, Asta-Werke AG, Degussa Pharma Gruppe, Bielefeld, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zechel", 
        "givenName": "Hans-Juergen", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00284124", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013128331", 
          "https://doi.org/10.1007/bf00284124"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00284124", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013128331", 
          "https://doi.org/10.1007/bf00284124"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0046-8177(74)80028-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017917668"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00964578", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025565295", 
          "https://doi.org/10.1007/bf00964578"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0277-5379(82)90143-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033699183"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0014-2964(81)90261-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042755367"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075292450", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1080302842", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082206891", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1984-06", 
    "datePublishedReg": "1984-06-01", 
    "description": "The LD 50 of Z 7557 in mice was between 500 and 625 mg/kg after i.v. and around 2310 mg/kg after oral administration. The corresponding LD 10 was around 435 mg/kg (i.v.) or 1100-1250 mg/kg (p.o.), respectively. The LD 50 values in rats were in the range of 250-310 mg/kg after i.v. administration and around 1000-1250 mg/kg if given orally. With repeated daily i.v. injections only 70% of the daily dose contributed to lethality. A second administration of Z 7557 to rats after reversal of all toxic signs from the first administration induced the same symptoms and degree of toxicity as the initial injection. Reversible myelosuppression was the predominant feature of toxicity in mice and rats, but at equimolar doses this myelotoxicity was less than half that of cyclophosphamide (CP). First signs of immunosuppression were seen only at 100 mg/kg i.v.. No severe urotoxicity was observed in rats with single i.v. doses up to 192 mg/kg. This might be due to the fast and complete renal excretion of the thiol moiety of Z 7557, whereas the activated oxazaphosphorine component occurred in the urine only to a much smaller amount, as could be shown by a pilot pharmacokinetic study. In conclusion, Z 7557 appeared to have an overall tolerance in rats and mice similar to cyclophosphamide but was clearly less toxic with respect to the bone marrow, the immune system and the urinary tract.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/bf00232352", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1094201", 
        "issn": [
          "0167-6997", 
          "1573-0646"
        ], 
        "name": "Investigational New Drugs", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "2"
      }
    ], 
    "name": "Experimental toxicology of ASTA Z 7557 (INN mafosfamide)", 
    "pagination": "201-206", 
    "productId": [
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf00232352"
        ]
      }, 
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "6fc8dac888e022b34fd210a883396fe0d63458355fa472e93ece719f7e0e1a03"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1023463040"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8309330"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "6469515"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf00232352", 
      "https://app.dimensions.ai/details/publication/pub.1023463040"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-15T09:01", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000375_0000000375/records_91444_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/BF00232352"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00232352'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00232352'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00232352'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00232352'


 

This table displays all metadata directly associated to this object as RDF triples.

159 TRIPLES      21 PREDICATES      48 URIs      32 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf00232352 schema:about N267b521e5efb451d99d2394692d50d3f
2 N286479853c4044d08d64e302a04a5575
3 N306eed65cb844b41a2f0157f92e628d5
4 N5f8c11fbd1184069812e86769d51d019
5 N88d5d65f85e14210b0aa67c1909fbaa4
6 N8c2a4d7de57c439296c099c3c0f70806
7 N99a05259cb684c9185ad939fea3c2cdf
8 Nab8d2a8fe14041458bfd7b43fce4b8a3
9 Naf614f356645479f99e6d9392e093f54
10 Nbf567ddab7fa4fcca74fe5854ded464f
11 Nf97a873ff6b8427bb7b4ee7dd0e481da
12 anzsrc-for:11
13 anzsrc-for:1115
14 schema:author N54bf9910ce3c4a83937a37ece229ac9b
15 schema:citation sg:pub.10.1007/bf00284124
16 sg:pub.10.1007/bf00964578
17 https://app.dimensions.ai/details/publication/pub.1075292450
18 https://app.dimensions.ai/details/publication/pub.1080302842
19 https://app.dimensions.ai/details/publication/pub.1082206891
20 https://doi.org/10.1016/0014-2964(81)90261-9
21 https://doi.org/10.1016/0277-5379(82)90143-2
22 https://doi.org/10.1016/s0046-8177(74)80028-6
23 schema:datePublished 1984-06
24 schema:datePublishedReg 1984-06-01
25 schema:description The LD 50 of Z 7557 in mice was between 500 and 625 mg/kg after i.v. and around 2310 mg/kg after oral administration. The corresponding LD 10 was around 435 mg/kg (i.v.) or 1100-1250 mg/kg (p.o.), respectively. The LD 50 values in rats were in the range of 250-310 mg/kg after i.v. administration and around 1000-1250 mg/kg if given orally. With repeated daily i.v. injections only 70% of the daily dose contributed to lethality. A second administration of Z 7557 to rats after reversal of all toxic signs from the first administration induced the same symptoms and degree of toxicity as the initial injection. Reversible myelosuppression was the predominant feature of toxicity in mice and rats, but at equimolar doses this myelotoxicity was less than half that of cyclophosphamide (CP). First signs of immunosuppression were seen only at 100 mg/kg i.v.. No severe urotoxicity was observed in rats with single i.v. doses up to 192 mg/kg. This might be due to the fast and complete renal excretion of the thiol moiety of Z 7557, whereas the activated oxazaphosphorine component occurred in the urine only to a much smaller amount, as could be shown by a pilot pharmacokinetic study. In conclusion, Z 7557 appeared to have an overall tolerance in rats and mice similar to cyclophosphamide but was clearly less toxic with respect to the bone marrow, the immune system and the urinary tract.
26 schema:genre research_article
27 schema:inLanguage en
28 schema:isAccessibleForFree false
29 schema:isPartOf N1e977e7f4c754af9a6e6411de376d76f
30 N4af1990f6610438dbe17384dc607b90c
31 sg:journal.1094201
32 schema:name Experimental toxicology of ASTA Z 7557 (INN mafosfamide)
33 schema:pagination 201-206
34 schema:productId N21d1cccbbc3c4bb6a9fe8aa279ef9c00
35 N5a2c5eeaa85144ed99d90aff5d7cc3fc
36 N681bfe7ffaa9469c929df9458981474d
37 Nb898ec71f6994c6d900dc879d8ce5d35
38 Nc1c7f27d64ec4c74b61781873769a6d4
39 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023463040
40 https://doi.org/10.1007/bf00232352
41 schema:sdDatePublished 2019-04-15T09:01
42 schema:sdLicense https://scigraph.springernature.com/explorer/license/
43 schema:sdPublisher Ne011941934e24c14bca3ca758049e484
44 schema:url http://link.springer.com/10.1007/BF00232352
45 sgo:license sg:explorer/license/
46 sgo:sdDataset articles
47 rdf:type schema:ScholarlyArticle
48 N1a1e5371c43442bd8e03233ea8ecb919 schema:affiliation Nbabba42d8ebb426ca32cc616acb71f19
49 schema:familyName Zechel
50 schema:givenName Hans-Juergen
51 rdf:type schema:Person
52 N1e977e7f4c754af9a6e6411de376d76f schema:volumeNumber 2
53 rdf:type schema:PublicationVolume
54 N1fcb2f89ed0545baa5cf7a6628e78633 schema:affiliation N3539e6eaf746440bb79cd06ffb4daf24
55 schema:familyName Hilgard
56 schema:givenName Peter
57 rdf:type schema:Person
58 N21d1cccbbc3c4bb6a9fe8aa279ef9c00 schema:name dimensions_id
59 schema:value pub.1023463040
60 rdf:type schema:PropertyValue
61 N267b521e5efb451d99d2394692d50d3f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
62 schema:name Cyclophosphamide
63 rdf:type schema:DefinedTerm
64 N286479853c4044d08d64e302a04a5575 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
65 schema:name Rats
66 rdf:type schema:DefinedTerm
67 N306eed65cb844b41a2f0157f92e628d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
68 schema:name Antibody Formation
69 rdf:type schema:DefinedTerm
70 N3539e6eaf746440bb79cd06ffb4daf24 schema:name Department of Experimental Cancer Research and Toxicological Institute, Asta-Werke AG, Degussa Pharma Gruppe, Bielefeld, Germany
71 rdf:type schema:Organization
72 N3b53315fdca94479a94555f6bb41d2fb schema:name Department of Experimental Cancer Research and Toxicological Institute, Asta-Werke AG, Degussa Pharma Gruppe, Bielefeld, Germany
73 rdf:type schema:Organization
74 N4af1990f6610438dbe17384dc607b90c schema:issueNumber 2
75 rdf:type schema:PublicationIssue
76 N50fff86edbb945c2be750baad3b97212 rdf:first N1a1e5371c43442bd8e03233ea8ecb919
77 rdf:rest rdf:nil
78 N510a638d8e1e4a1ea1d5f8e2f02228df rdf:first sg:person.0672360256.43
79 rdf:rest N50fff86edbb945c2be750baad3b97212
80 N54bf9910ce3c4a83937a37ece229ac9b rdf:first Nf5bba1c1b91244c68240878e436d9a66
81 rdf:rest Ne9a3a1cd555344b192ff7d2963f86061
82 N5a2c5eeaa85144ed99d90aff5d7cc3fc schema:name pubmed_id
83 schema:value 6469515
84 rdf:type schema:PropertyValue
85 N5f8c11fbd1184069812e86769d51d019 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Animals
87 rdf:type schema:DefinedTerm
88 N681bfe7ffaa9469c929df9458981474d schema:name doi
89 schema:value 10.1007/bf00232352
90 rdf:type schema:PropertyValue
91 N88d5d65f85e14210b0aa67c1909fbaa4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Mice
93 rdf:type schema:DefinedTerm
94 N8c2a4d7de57c439296c099c3c0f70806 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Lethal Dose 50
96 rdf:type schema:DefinedTerm
97 N8ee357bdb92d4d109cca16f38050cd5c schema:name Department of Experimental Cancer Research and Toxicological Institute, Asta-Werke AG, Degussa Pharma Gruppe, Bielefeld, Germany
98 rdf:type schema:Organization
99 N99a05259cb684c9185ad939fea3c2cdf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Bone Marrow
101 rdf:type schema:DefinedTerm
102 Nab8d2a8fe14041458bfd7b43fce4b8a3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Rats, Inbred Strains
104 rdf:type schema:DefinedTerm
105 Naf614f356645479f99e6d9392e093f54 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Organ Size
107 rdf:type schema:DefinedTerm
108 Nb898ec71f6994c6d900dc879d8ce5d35 schema:name readcube_id
109 schema:value 6fc8dac888e022b34fd210a883396fe0d63458355fa472e93ece719f7e0e1a03
110 rdf:type schema:PropertyValue
111 Nbabba42d8ebb426ca32cc616acb71f19 schema:name Department of Experimental Cancer Research and Toxicological Institute, Asta-Werke AG, Degussa Pharma Gruppe, Bielefeld, Germany
112 rdf:type schema:Organization
113 Nbf567ddab7fa4fcca74fe5854ded464f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Urinary Bladder
115 rdf:type schema:DefinedTerm
116 Nc1c7f27d64ec4c74b61781873769a6d4 schema:name nlm_unique_id
117 schema:value 8309330
118 rdf:type schema:PropertyValue
119 Ne011941934e24c14bca3ca758049e484 schema:name Springer Nature - SN SciGraph project
120 rdf:type schema:Organization
121 Ne9a3a1cd555344b192ff7d2963f86061 rdf:first N1fcb2f89ed0545baa5cf7a6628e78633
122 rdf:rest N510a638d8e1e4a1ea1d5f8e2f02228df
123 Nf5bba1c1b91244c68240878e436d9a66 schema:affiliation N3b53315fdca94479a94555f6bb41d2fb
124 schema:familyName Pohl
125 schema:givenName Joerg
126 rdf:type schema:Person
127 Nf97a873ff6b8427bb7b4ee7dd0e481da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Kinetics
129 rdf:type schema:DefinedTerm
130 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
131 schema:name Medical and Health Sciences
132 rdf:type schema:DefinedTerm
133 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
134 schema:name Pharmacology and Pharmaceutical Sciences
135 rdf:type schema:DefinedTerm
136 sg:journal.1094201 schema:issn 0167-6997
137 1573-0646
138 schema:name Investigational New Drugs
139 rdf:type schema:Periodical
140 sg:person.0672360256.43 schema:affiliation N8ee357bdb92d4d109cca16f38050cd5c
141 schema:familyName Jahn
142 schema:givenName Wolfgang
143 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0672360256.43
144 rdf:type schema:Person
145 sg:pub.10.1007/bf00284124 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013128331
146 https://doi.org/10.1007/bf00284124
147 rdf:type schema:CreativeWork
148 sg:pub.10.1007/bf00964578 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025565295
149 https://doi.org/10.1007/bf00964578
150 rdf:type schema:CreativeWork
151 https://app.dimensions.ai/details/publication/pub.1075292450 schema:CreativeWork
152 https://app.dimensions.ai/details/publication/pub.1080302842 schema:CreativeWork
153 https://app.dimensions.ai/details/publication/pub.1082206891 schema:CreativeWork
154 https://doi.org/10.1016/0014-2964(81)90261-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042755367
155 rdf:type schema:CreativeWork
156 https://doi.org/10.1016/0277-5379(82)90143-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033699183
157 rdf:type schema:CreativeWork
158 https://doi.org/10.1016/s0046-8177(74)80028-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017917668
159 rdf:type schema:CreativeWork
 




Preview window. Press ESC to close (or click here)


...